Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginsenoside Rg2 is a naturally occurring saponin compound classified as a ginsenoside and is found in Panax species such as Panax ginseng. It is a dammarane-type tetracyclic triterpenoid glycoside with multiple hydroxy substitutions and sugar moieties. Ginsenoside Rg2 exhibits diverse pharmacological activities including cardioprotective effects (notably against drug-induced cardiotoxicity), neuroprotective actions (protection of nerve cells and potential benefit in cognitive impairment), anti-inflammatory properties (suppression of pro-inflammatory signaling pathways), anticoagulant activity, and anti-diabetic effects. Mechanistically, it modulates several cellular signaling pathways such as NF-κB inhibition; regulation of MAPK/ERK pathway; PI3K/Akt/mTOR pathway modulation; AMPK activation leading to reduced hepatic glucose production; inhibition of apoptosis via caspase regulation; suppression of cell adhesion molecules like VCAM-1 and ICAM-1 under inflammatory conditions; regulation of 5-HT3A receptors and nicotinic acetylcholine receptor-mediated ion fluxes. Its therapeutic potential has been explored for type 2 diabetes mellitus, vascular dementia or other ischemic insults to the nervous system, myocardial injury/apoptosis prevention especially in the context of trastuzumab-induced cardiotoxicity in preclinical models[1][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginsenoside Rg2.